IP Library Granted Patent US 7,605,121
Granted Patent B2
US 7,605,121 · App. 11/039,997 · Granted Oct 20, 2009

Oligopeptide lyophilisate, their preparation and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,605,121
App. No.
11/039,997
Granted
Oct 20, 2009
Kind
B2
Abstract

A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried.

Claims (9)

1. A sterile Cetrorelix acetate-bulking agent lyophilisate prepared by a method comprising the steps of:

(a) dissolving having the amino acid sequence of Ac-D-Nal(2)-D-pCl-Phe-D-Pal(3)-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH 2 (SEQ ID NO: 1) in 30% (v/v) aqueous acetic acid to form a solution;

(b) diluting the solution with water;

(c) adding bulking agent to the solution, after which the solution has a pH range between 2.5-3.0;

(d) sterilizing the solution by filtration; and

(e) lyophilizing the solution, producing a sterile Cetrorelix acetate lyophilisate-bulking agent thereby.

2. The sterile Cetrorelix acetate-bulking agent lyophilisate according to claim 1 wherein the bulking agent is a conventional pharmaceutical auxiliary selected from the group consisting of amino acids, polyvinylpyrrolidone, albumin, a hexitol, urea, and sodium chloride.

3. The sterile Cetrorelix acetate-bulking agent lyophilisate according to claim 2 wherein the hexitol is selected from the group consisting of mannitol, glucitol, sorbitol, D-sorbitol, dulcitol, allitol, and iditol, and wherein the bulking agent in the lyophilisate is in an amount from 0.1 to 17 parts by weight per 1 part by weight of the peptide.

4. The sterile Cetrorelix acetate-bulking agent lyophilisate according to claim 1 wherein 1 part by weight of the peptide is dissolved in 100-10,000 parts by weight 30% (v/v) aqueous acetic acid and wherein the solution is diluted with water to 3% (v/v) aqueous acetic acid and wherein the bulking agent is mannitol.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2012
From: AETERNA ZENTARIS GMBH
To: ZENTARIS IVF GMBH
Reel/Frame 027886/0381 →
CHANGE OF NAME Recorded Feb 2, 2012
From: ZENTARIS GMBH
To: AETERNA ZENTARIS GMBH
Reel/Frame 027646/0117 →
SECURITY AGREEMENT Recorded Nov 22, 2011
From: COWEN HEALTHCARE ROYALTY PARTNERS, L.P. (SUCCESSOR OF CETRO INVESTORS, L.P.); VANDERBILT ROYALTY HOLDINGS L.P.; VANDERBILT ROYALTY SUB L.P.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 027278/0184 →
SECURITY AGREEMENT Recorded Nov 22, 2011
From: ZENTARIS IVF GMBH
To: CETRO INVESTORS, L.P.
Reel/Frame 027278/0053 →
MERGER Recorded Oct 28, 2009
From: ZENTARIS AG
To: BLITZ F02-570 GMBH
Reel/Frame 023427/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2009
From: ENGEL, JURGEN; WICHERT, BURKHARD; SAUERBIER, DIETER; REISSMANN, THOMAS
To: ZENTARIS AG
Reel/Frame 023436/0737 →
CHANGE OF NAME Recorded Oct 28, 2009
From: BLITZ F02-570 GMBH
To: ZENTARIS GMBH
Reel/Frame 023438/0004 →